According to a report, “Controlled Release Drug Delivery Market Analysis Report By Technology (Implants, Transdermal, Microencapsulation, Targeted Delivery), By Release Mechanism, By Application, And Segment Forecasts, 2018 – 2025″ , published by Grand View Research, Inc., The global controlled release drug delivery market size is expected to reach USD 90.18 billion by 2025,experiencing a CAGR of 14.0% during the forecast period. Soaring need for geriatric and pediatric controlled release delivery techniques and alternative therapies and rising awareness regarding benefits of these systems over conventional forms are providing a fillip to the market.
Key Takeaways from the report:
On the basis of application, oral controlled release systems held the largest share in the market in 2017 owing to increasing usage and ease of convenience offered for administration of medication
Targeted drug delivery is poised to be the fastest growth technology segment during the forecast period owing to its various benefits
Osmotic delivery, based on activation modulation drug delivery systems, is likely to witness the highest CAGR due to its ability to not be affected by various factors, such as pH, food consumption, and gastrointestinal motility
Asia Pacific is expected to post the highest CAGR during the forecast period owing to rising investments by dominant players in the region and developments in the of pharmaceutical industry in emerging countries, such as India and China
Some of the prominent companies operating in the market are Orbis Biosciences, Inc.; Merck and Co., Inc.; Alkermes plc; Johnson and Johnson; Coating Place, Inc.; Corium International, Inc.; Depomed, Inc.; Pfizer, Inc; Aradigm Corporation; and Capsugel.
These technologies offer various benefits over traditional delivery forms. Reduced dosage and dosage frequency, less gastrointestinal side effects, enhanced patient compliance, uniform drug effect, improved drug efficacy and safety, and reduced fluctuation of plasma drug levels are some of the benefits offered by these technologies.
Have some specific queries about this report, our team of analyst will be glad to help!
Dysphagia in geriatric population and unpleasant taste of pediatric dosages are playing a vital role in boosting the adoption of controlled release drug delivery systems. According to a report published by Orbis Biosciences, with reduction in frequency of dosages, compliance rates are witnessed to increase. Innovations in various drug delivery systems has been providing geriatric and pediatric population with easy solutions, which are further propelling the market. Controlled release of drugs allows reduction in overdose in elderly population as they can be altered according to required dosage over a specific period of time.
Access complete Pharmaceuticals Report Portfolio By Grand View research, Inc.
North America is estimated to be at the forefront of the market throughout the forecast period due to technologically advanced infrastructure, increasing R&D activities, and presence of major players and pharmaceutical companies in the region. Emerging countries such as India, China, and Brazil are also anticipated to register promising growth during the same period owing to improving healthcare infrastructure and medical technologies to cater to specific patient care. On similar lines, Asia Pacific is projected to post the highest CAGR during the forecast period.
Grand View Research has segmented the global controlled release drug delivery market on the basis of technology, release mechanism, application, and region:
Controlled Release Drug Delivery Technology Outlook (Revenue, USD Billion, 2014 – 2025)
Wurster Technique
Coacervation
Micro Encapsulation
Implants
Transdermal
Targeted Delivery
Others
Controlled Release Drug Delivery Release Mechanism Outlook (Revenue, USD Billion, 2014 – 2025)
Polymer Based Systems
Micro Reservoir Partition Controlled Drug Delivery Systems
Feedback Regulated Drug Delivery Systems
Activation-modulated Drug Delivery Systems
Osmotic Pressure Activated
Hydrodynamic Pressure Activated
Vapor Pressure Activated
Mechanically Activated
Magnetically Activated
Chemically Activated
pH Activated
Hydrolysis Activated
Enzyme Activated
Controlled Release Drug Delivery Application Outlook (Revenue, USD Billion, 2014 – 2025)
Metered Dose Inhalers
Injectable
Transdermal and Ocular Patches
Infusion Pumps
Oral Controlled-drug delivery Systems
Drug Eluting Stents
Controlled Release Drug Delivery Regional Outlook (Revenue, USD Billion, 2014 – 2025)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Asia Pacific
Japan
China
India
Latin America
Brazil
Mexico
Middle East and Africa
South Africa
Saudi Arabia
Check out special pricing options for sectional purchase and startup companies
About Grand View ResearchGrand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.For more information: www.grandviewresearch.com/
Media ContactCompany Name: Grand View Research, Inc.Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.Email: Send EmailPhone: 1-415-349-0058, Toll Free: 1-888-202-9519Address:201, Spear Street, 1100 City: San FranciscoState: CaliforniaCountry: SwitzerlandWebsite: www.grandviewresearch.com/industry-analysis/controlled-release-drug-delivery-market
